Dioscin enhances methotrexate absorption by down-regulating MDR1 in vitro and in vivo.
Toxicol Appl Pharmacol
; 277(2): 146-54, 2014 Jun 01.
Article
en En
| MEDLINE
| ID: mdl-24680847
The purpose of this study was to investigate the enhancing effect of dioscin on the absorption of methotrexate (MTX) and clarify the molecular mechanism involved in vivo and in vitro. Dioscin increased MTX chemosensitivity and transepithelial flux in the absorptive direction, significantly inhibiting multidrug resistance 1 (MDR1) mRNA and protein expression and MDR1 promoter and nuclear factor κ-B (NF-κB) activities in Caco-2 cells. Moreover, inhibitor κB-α (IκB-α) degradation was inhibited by dioscin. Dioscin enhanced the intracellular concentration of MTX by down-regulating MDR1 expression through a mechanism that involves NF-κB signaling pathway inhibition in Caco-2 cells. Dioscin strengthened MTX absorption by inhibiting MDR1 expression in rat intestine. In addition, even though MTX is absorbed into the enterocytes, there was no increase in toxicity observed, and that, in fact, decreased toxicity was seen.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Metotrexato
/
Miembro 1 de la Subfamilia B de Casetes de Unión a ATP
/
Subfamilia B de Transportador de Casetes de Unión a ATP
/
Enterocitos
/
Diosgenina
/
Absorción Intestinal
/
Intestino Delgado
/
Antimetabolitos Antineoplásicos
Límite:
Animals
/
Humans
/
Male
Idioma:
En
Revista:
Toxicol Appl Pharmacol
Año:
2014
Tipo del documento:
Article
Pais de publicación:
Estados Unidos